Literature DB >> 29086692

Macrophage Polarization as a Therapeutic Target in Myocardial Infarction.

Yuanyuan Cheng1, Jianhui Rong1.   

Abstract

BACKGROUND: Myocardial infarction is characterized by the interruption of blood flow through the heart, directly causing mortality and disability worldwide. Cardiac macrophages exhibit distinct phenotypes (e.g., M1 or M2) and functions (e.g., proinflammatory or anti-inflammatory) in response to the alterations of myocardial microenvironment, and subsequently exacerbate or resolve inflammation in the infarcted hearts. Regulation of macrophage polarization was implicated in myocardial infarction for the quality and outcome of cardiac healing.
OBJECTIVE: The purpose of this review was to summarise the current understanding on the regulation of macrophage polarization in myocardial infarction and highlight the therapeutic potential of pharmacological regulators in the treatment of myocardial injury via modulating macrophage polarization.
RESULTS: Timely control of M2/M1 ratio by endogenous mediators and pharmacological regulators should help the resolution of inflammation, promote wound healing and prevent cardiac fibrosis after myocardial infarction.
CONCLUSION: Macrophage polarization deserves better investigations as the therapeutic target for the development of novel drugs against myocardial injury. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Myocardial infarction; cardiac healing; drug discovery; inflammation; macrophage polarization; molecular mechanism.

Mesh:

Year:  2018        PMID: 29086692     DOI: 10.2174/1389450118666171031115025

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  20 in total

1.  Histamine Deficiency Promotes Myofibroblasts Transformation from HDC-Expressing CD11b+ Myeloid Cells in Injured Hearts Post Myocardial Infarction.

Authors:  Baoling Zhu; Xiaowei Zhu; Xiangfei Wang; Jian Wu; Suling Ding; Weiwei Zhang; Yunzeng Zou; Junbo Ge; Xiangdong Yang
Journal:  J Cardiovasc Transl Res       Date:  2021-11-03       Impact factor: 3.216

Review 2.  Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction.

Authors:  Mira Jung; Michael Dodsworth; Thomas Thum
Journal:  Basic Res Cardiol       Date:  2018-12-06       Impact factor: 17.165

3.  Mechanical stretch induces hair regeneration through the alternative activation of macrophages.

Authors:  Szu-Ying Chu; Chih-Hung Chou; Hsien-Da Huang; Meng-Hua Yen; Hsiao-Chin Hong; Po-Han Chao; Yu-Hsuan Wang; Po-Yu Chen; Shi-Xin Nian; Yu-Ru Chen; Li-Ying Liou; Yu-Chen Liu; Hui-Mei Chen; Feng-Mao Lin; Yun-Ting Chang; Chih-Chiang Chen; Oscar K Lee
Journal:  Nat Commun       Date:  2019-04-03       Impact factor: 14.919

4.  C1q/TNF-related protein-9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction.

Authors:  Mingxin Liu; Lin Yin; Wei Li; Juan Hu; Huibo Wang; Bingjie Ye; Yanhong Tang; Congxin Huang
Journal:  J Cell Physiol       Date:  2019-04-05       Impact factor: 6.384

5.  Compromised Anti-inflammatory Action of Neutrophil Extracellular Traps in PAD4-Deficient Mice Contributes to Aggravated Acute Inflammation After Myocardial Infarction.

Authors:  Kaveh Eghbalzadeh; Leena Georgi; Theresa Louis; Haizhi Zhao; Ugur Keser; Carolyn Weber; Martin Mollenhauer; Andreas Conforti; Thorsten Wahlers; Adnana Paunel-Görgülü
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

6.  Asaronic Acid Inhibited Glucose-Triggered M2-Phenotype Shift Through Disrupting the Formation of Coordinated Signaling of IL-4Rα-Tyk2-STAT6 and GLUT1-Akt-mTOR-AMPK.

Authors:  Hyeongjoo Oh; Sin-Hye Park; Min-Kyung Kang; Yun-Ho Kim; Eun-Jung Lee; Dong Yeon Kim; Soo-Il Kim; Su Yeon Oh; Woojin Na; Soon Sung Lim; Young-Hee Kang
Journal:  Nutrients       Date:  2020-07-06       Impact factor: 5.717

7.  Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling.

Authors:  Jeremie Lemarié; Ivana Zlatanova; Icia Santos-Zas; Marine Cachanado; Jean-Christophe Seghezzi; Hakim Benamer; Pascal Goube; Marie Vandestienne; Raphael Cohen; Maya Ezzo; Vincent Duval; Yujiao Zhang; Jin-Bo Su; Alain Bizé; Lucien Sambin; Philippe Bonnin; Maxime Branchereau; Christophe Heymes; Corinne Tanchot; José Vilar; Clement Delacroix; Jean-Sebastien Hulot; Clement Cochain; Patrick Bruneval; Nicolas Danchin; Alain Tedgui; Ziad Mallat; Tabassome Simon; Bijan Ghaleh; Jean-Sébastien Silvestre; Hafid Ait-Oufella
Journal:  Nat Commun       Date:  2021-03-05       Impact factor: 14.919

Review 8.  Plasminogen activation in the musculoskeletal acute phase response: Injury, repair, and disease.

Authors:  Breanne H Y Gibson; Matthew T Duvernay; Stephanie N Moore-Lotridge; Matthew J Flick; Jonathan G Schoenecker
Journal:  Res Pract Thromb Haemost       Date:  2020-06-14

9.  N-Propargyl caffeate amide (PACA) prevents cardiac fibrosis in experimental myocardial infarction by promoting pro-resolving macrophage polarization.

Authors:  Yuanyuan Cheng; Dan Luo; Yingke Zhao; Jianhui Rong
Journal:  Aging (Albany NY)       Date:  2020-03-23       Impact factor: 5.682

10.  CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post-Myocardial Infarction Rats.

Authors:  Mingxin Liu; Wei Li; Huibo Wang; Lin Yin; Bingjie Ye; Yanhong Tang; Congxin Huang
Journal:  J Am Heart Assoc       Date:  2019-10-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.